The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils
Open accessAbstract
Imaging the progression of Alzheimer's disease would greatly facilitate the discovery of therapeutics, and a wide range of ligands are currently under development for the detection of beta-amyloid peptide (Abeta)-containing plaques by using positron emission tomography. Here we report an in-depth characterization of the binding of seven previously described ligands to in vitro generated Abeta-(1-40) polymers. All of the compounds were derived from the benzothiazole compound thioflavin T and include 2-[4'-(methylamino)phenyl]benzothiazole and 2-(4'-dimethylamino-)phenyl-imidazo[1,2-a]-pyridine derivatives, 2-[4'-(dimethylamino)phenyl]-6-iodobenzothiazole and 2-[4'-(4''-methylpiperazin-1-yl)phenyl]-6-iodobenzothiazole, and a benzofuran compound (5-bromo-2-(4-dimethylaminophenyl)benzofuran). By using a range of fluorescent and radioligand binding assays, we find that these compounds display a more complex binding pattern than described previously and are consistent with three classes of binding sites on the Abeta fibrils. All of the compounds bound with very high affinity (low nm K(d)) to a low capacity site (BS3) (1 ligand-binding site per approximately 300 Abeta-(1-40) monomers) consistent with the previously recognized binding site for these compounds on the fibrils. However, the compounds also bound with high affinity (K(d) approximately 100 nm) to either one of two additional binding sites on the Abeta-(1-40) polymer. The properties of these sites, BS1 and BS2, suggest they are adjacent or partially overlapping and have a higher capacity than BS3, occurring every approximately 35 or every approximately 4 monomers of Abeta-(1-40)-peptide, respectively. Compounds appear to display selectivity for BS2 based on the presence of a halogen substitution (2-[4'-(dimethylamino)phenyl]-6-iodobenzothiazole, 2-[4'-(4''-methylpiperazin-1-yl)phenyl]-6-iodobenzothiazole, and 5-bromo-2-(4-dimethylaminophenyl)benzofuran) on their aromatic ring system. The presence of additional ligand-binding sites presents potential new targets for ligand development and may allow a more complete modeling of the current positron emission tomography data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies were performed with Aβ fibrils obtained from the Aβ40 peptide, which forms more homogenous fibrillar structures without any non-fibrillar aggregates (Figure S21a).83,84”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Titrations with various amounts of compounds reveal competitive binding curves that yield Ki values 180±25 nM and 36±6 nM for L1 and L2, respectively (Figure 6b).84,85”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, most of these previous studies have employed the Aβ40 peptide that follows a more direct aggregation pathway to form homogenous, well-defined fibrillar structures.83,84”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that the Ki value for L1 is smaller than the Kd value, which is most likely due to the fact that ThT binds with different affinities to more than one site to the Aβ fibrils.47”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies were performed with Aβ40 fibrils, which form more homogeneous fibrillar structures without any nonfibrillar aggregates.45,47”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
LeVine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,284
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
Naiki, H., Higuchi, K., Hosokawa, M., & Takeda, T. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90046-8 · Cited by 1,244
Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
Mathis, C. A., Wang, Y., Holt, D. P., Huang, G.-F., Debnath, M. L., & Klunk, W. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030026b · Cited by 976
Alzheimer’s amyloid fibrils: structure and assembly
Serpell, L. C. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00029-6 · Cited by 973
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 829
PET imaging of amyloid in Alzheimer's disease
Nordberg, A. K. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 462
Research works printed but not linked: 3
- Small, 2002, J. Mol. Neurosci., 19, 323
- Nilsson, 2004, Methods (Orlando), 34, 151
- Vassar, 1959, Arch. Pathol., 68, 487
Cited by
Sorted by citations
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
Groenning, M. (2009) · Journal of Chemical Biology · doi:10.1007/s12154-009-0027-5 · Cited by 655
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 614
Reinke, A. A., & Gestwicki, J. E. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00557.x · Cited by 335
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Self-citationInterrogating Amyloid Aggregates using Fluorescent Probes
Aliyan, A., Cook, N. P., & Martí, A. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00404 · Cited by 298
Atamna, H., & Boyle, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600134103 · Cited by 291
Rowe, C. C., & Villemagne, V. L. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076315 · Cited by 279
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 242
Congo red and thioflavin‐T analogs detect Aβ oligomers
Maezawa, I., Hong, H., Liu, R., Wu, C., Cheng, R. H., Kung, M., Kung, H. F., Lam, K. S., Oddo, S., LaFerla, F. M., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04972.x · Cited by 230
Thermodynamics of Aβ(1−40) Amyloid Fibril Elongation
O’Nuallain, B., Shivaprasad, S., Kheterpal, I., & Wetzel, R. B. (2005) · Biochemistry · doi:10.1021/bi050927h · Cited by 215
Okamura, N., Suemoto, T., Furumoto, S., Suzuki, M., Shimadzu, H., Akatsu, H., Yamamoto, T., Fujiwara, H., Nemoto, M., Maruyama, M., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1738-05.2005 · Cited by 212
Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide
Sharma, A. K., Pavlova, S. T., Kim, J., Finkelstein, D., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210588m · Cited by 202
Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease
Hayne, D. J., Lim, S., & Donnelly, P. S. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00026a · Cited by 178
Curcumin‐Derived Pyrazoles and Isoxazoles: Swiss Army Knives or Blunt Tools for Alzheimer's Disease?
Narlawar, R., Pickhardt, M., Leuchtenberger, S., Baumann, K., Krause, S., Dyrks, T., Weggen, S., Mandelkow�, E., & Schmidt, B. (2007) · ChemMedChem · doi:10.1002/cmdc.200700218 · Cited by 177
Villemagne, V. L., Ataka, S., Mizuno, T., Brooks, W. S., Wada, Y., Kondo, M., Jones, G. R., Watanabe, Y., Mulligan, R. S., Nakagawa, M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.285 · Cited by 176
Sulatskaya, A. I., Maskevich, A. A., Kuznetsova, I. М., Uversky, V. N., & Константинович, Т. К. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015385 · Cited by 172
Insight into Amyloid Structure Using Chemical Probes
Reinke, A. A., & Gestwicki, J. E. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01110.x · Cited by 173
Amyloid fibril polymorphism: a challenge for molecular imaging and therapy
Fändrich, M., Nyström, S., Nilsson, K. P. R., Böckmann, A., LeVine, H., & Hammarström, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12732 · Cited by 165
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154
Discovery of Small Molecules that Induce the Degradation of Huntingtin
Tomoshige, S., Nomura, S., Ohgane, K., Hashimoto, Y., & Ishikawa, M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706529 · Cited by 144
Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives
Pithadia, A. S., Brender, J., Fierke, C. A., & Ramamoorthy, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/2046327 · Cited by 142
Wu, C. F., Wang, Z., Lei, H., Duan, Y., Bowers, M. T., & Shea, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.062 · Cited by 141
Binding Modes of Thioflavin-T to the Single-Layer β-Sheet of the Peptide Self-Assembly Mimics
Wu, C. F., Biancalana, M., Koide, S., & Shea, J. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.056 · Cited by 138
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies
Thompson, P. W., Ye, L., Morgenstern, J. L., Sue, L. I., Beach, T. G., Judd, D. J., Shipley, N. J., Libri, V., & Lockhart, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05996.x · Cited by 133
Self-citationAmyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue
Ni, R., Gillberg, P., Bergfors, A., Marutle, A., & Nordberg, A. K. (2013) · Brain · doi:10.1093/brain/awt142 · Cited by 135
Interactions between Hsp70 and the Hydrophobic Core of α-Synuclein Inhibit Fibril Assembly
Luk, K. C., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Biochemistry · doi:10.1021/bi801475r · Cited by 137
A Role for Amyloid in Cell Aggregation and Biofilm Formation
Garcia, M. C., Lee, J. T., Ramsook, C. B., Alsteens, D., Dufrêne, Y. F., & Lipke, P. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017632 · Cited by 128
Gabelica, V., Maeda, R., Fujimoto, T., Yaku, H., Murashima, T., Sugimoto, N., & Miyoshi, D. (2013) · Biochemistry · doi:10.1021/bi4006072 · Cited by 120
Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voß, A., Huisman, M. C., Settles, M., Neff, F., Velden, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031310 · Cited by 121
Habib, L. K., Lee, M. T. C., & Yang, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132860 · Cited by 114
Sulatskaya, A. I., Kuznetsova, I. М., & Константинович, Т. К. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp207118x · Cited by 113
Molecules that Target beta‐Amyloid
Stains, C. I., Mondal, K., & Ghosh, I. (2007) · ChemMedChem · doi:10.1002/cmdc.200700140 · Cited by 113
On the binding of Thioflavin-T to HET-s amyloid fibrils assembled at pH 2
Sabaté, R., Lascu, I., & Saupe, S. J. (2008) · Journal of Structural Biology · doi:10.1016/j.jsb.2008.02.002 · Cited by 103
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Ikonomović, M. D., Buckley, C. J., Heurling, K., Sherwin, P. F., Jones, P. A., Zanette, M., Mathis, C. A., Klunk, W. E., Chakrabarty, A., Ironside, J. W., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0399-z · Cited by 102
Photo-induced inhibition of Alzheimer's β-amyloid aggregation in vitro by rose bengal
Lee, J., Lee, B. I., & Park, C. B. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.058 · Cited by 97
Amyloid imaging in Alzheimer??s disease
Nordberg, A. K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281a47744 · Cited by 98
Rosen, R. F., Walker, L. C., & LeVine, H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.011 · Cited by 100
A Review of Imaging Agent Development
Agdeppa, E. D., & Spilker, M. E. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9104-5 · Cited by 97
The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
Villemagne, V. L., Fodero‐Tavoletti, M. T., Pike, K. E., Cappai, R., Masters, C. L., & Rowe, C. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8019-y · Cited by 103
Delineation of Positron Emission Tomography Imaging Agent Binding Sites on β-Amyloid Peptide Fibrils
Ye, L., Morgenstern, J. L., Gee, A. D., Hong, G., Brown, J., & Lockhart, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501285200 · Cited by 97
Self-citationYe, L., Velasco, A. L., Fraser, G. M., Beach, T. G., Sue, L. I., Osredkar, T., Libri, V., Spillantini, M. G., Goedert, M., & Lockhart, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05245.x · Cited by 91
Self-citationWu, C. F., Bowers, M. T., & Shea, J. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.01.058 · Cited by 88
Styryl‐Based Compounds as Potential in vivo Imaging Agents for β‐Amyloid Plaques
Li, Q., Min, J., Ahn, Y., Namm, J., Kim, E. M., Lui, R., Kim, H. Y., Ji, Y., Wu, H., Wısnıewskı, T., et al. (2007) · ChemBioChem · doi:10.1002/cbic.200700154 · Cited by 86
Atamna, H., Frey, W. H., & Ko, N. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.003 · Cited by 88
Knight, W. D., Okello, A., Ryan, N. S., Turkheimer, F., de Llano, S. R. M., Edison, P., Douglas, J., Fox, N. C., Brooks, D. J., & Rossor, M. N. (2010) · Brain · doi:10.1093/brain/awq310 · Cited by 86
Snellman, A., Lopez‐Picon, F. R., Rokka, J., Salmona, M., Forloni, G., Scheinin, M., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110163 · Cited by 83
Analyzing Thioflavin T Binding to Amyloid Fibrils by an Equilibrium Microdialysis-Based Technique
Kuznetsova, I. М., Sulatskaya, A. I., Uversky, V. N., & Константинович, Т. К. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030724 · Cited by 81
Sidhu, A., Vaneyck, J., Blum, C., Segers‐Nolten, I. M. J., & Subramaniam, V. (2018) · Amyloid · doi:10.1080/13506129.2018.1517736 · Cited by 76
Differentiating Alzheimer disease-associated aggregates with small molecules
Honson, N. S., Johnson, R. L., Huang, W., Inglese, J., Austin, C. P., & Kuret, J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.018 · Cited by 76
Cui, M., Ono, M., Kimura, H., Liu, B., & Saji, H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101404k · Cited by 76
Bandara, N., Sharma, A. K., Krieger, S., Schultz, J. W., Han, B. H., Rogers, B. E., & Mirica, L. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05937 · Cited by 82
Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice
Tanifum, E. A., Dasgupta, I., Srivastava, M., Bhavane, R. C., Sun, L., Berridge, J., Pourgarzham, H., Kamath, R., Espinosa, G., Cook, S. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048515 · Cited by 72
Deeg, A. A., Reiner, A. M., Schmidt, F., Schueder, F., Ryazanov, S., Ruf, V., Giller, K., Becker, S., Leonov, A., Griesinger, C., et al. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.05.021 · Cited by 75
Leuma Yona, R., Mazères, S., Faller, P., & Gras, E. (2008) · ChemMedChem · doi:10.1002/cmdc.200700188 · Cited by 72
Yousefi, B. H., Manook, A., Drzezga, A. E., von Reutern, B., Schwaiger, M., Wester, H., & Henriksen, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101129a · Cited by 73
Ono, M., Watanabe, R., Kawashima, H., Cheng, Y., Kimura, H., Watanabe, H., Haratake, M., Saji, H., & Nakayama, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901057p · Cited by 71
A molecular tweezer antagonizes seminal amyloids and HIV infection
Lump, E., Castellano, L. M., Meier, C. A., Seeliger, J., Erwin, N., Sperlich, B., Stürzel, C. M., Usmani, S. M., Hammond, R. M., von Einem, J., et al. (2015) · eLife · doi:10.7554/elife.05397 · Cited by 70
Kuznetsova, I. М., Sulatskaya, A. I., Uversky, V. N., & Константинович, Т. К. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8272-y · Cited by 69
Structure and Orientation of Peptide Inhibitors Bound to Beta-amyloid Fibrils
Chen, Z., Krause, G., & Reif, B. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.055 · Cited by 67
Rational Design of Amyloid Binding Agents Based on the Molecular Rotor Motif
Sutharsan, J., Dakanali, M., Capule, C. C., Haidekker, M. A., Yang, J., & Theodorakis, E. A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900440 · Cited by 67
Polyfluorinated Bis-styrylbenzene β-Amyloid Plaque Binding Ligands
Flaherty, D. P., Walsh, S. M., Kiyota, T., Dong, Y., Ikezu, T., & Vennerstrom, J. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070085f · Cited by 64
Synthesis and in vitro evaluation of α-synuclein ligands
Yu, L., Cui, J., Padakanti, P. K., Engel, L. A., Bagchi, D. P., Kotzbauer, P. T., & Tu, Z. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.06.023 · Cited by 64
Bort, G., Catoen, S., Borderies, H., Kebsi, A., Ballet, S., Louin, G., Port, M., & Ferroud, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.016 · Cited by 62
Huang, Y., Cho, H.-J., Bandara, N., Sun, L., Tran, D., Rogers, B. E., & Mirica, L. M. (2020) · Chemical Science · doi:10.1039/d0sc02641g · Cited by 62
Liu, Z., Deng, Q., Qin, G., Yang, J., Zhang, H., Ren, J., & Qu, X. (2023) · Chem · doi:10.1016/j.chempr.2023.06.003 · Cited by 59
Olsen, J. S., Brown, C. W., Capule, C. C., Rubinshtein, M., Doran, T. M., Srivastava, R. K., Feng, C., Nilsson, B. L., Yang, J., & Dewhurst, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163659 · Cited by 59
Imaging Alzheimer's disease pathology: one target, many ligands
Lockhart, A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.008 · Cited by 56
Self-citationKinetic Mechanism of Thioflavin T Binding onto the Amyloid Fibril of Hen Egg White Lysozyme
Qin, Z., Sun, Y., Jia, B., Wang, D., Ma, Y., & Ma, G. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b00221 · Cited by 55
Yousefi, B. H., Drzezga, A. E., von Reutern, B., Manook, A., Schwaiger, M., Wester, H., & Henriksen, G. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200123w · Cited by 54
Bauer, M., Langer, O., Dal‐Bianco, P., Karch, R., BRUNNER, M., Abrahim, A., Lanzenberger, R. R., HOFMANN, A., Joukhadar, C., & Carminati, P. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.05.007 · Cited by 53
Molecular polymorphism of Aβ in Alzheimer's disease
LeVine, H., & Walker, L. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.026 · Cited by 54
Sundaram, G. S. M., Dhavale, D. D., Prior, J. L., Yan, P., Cirrito, J. R., Rath, N. P., Laforest, R. A., Cairns, N. J., Lee, J., Kotzbauer, P. T., et al. (2016) · Scientific Reports · doi:10.1038/srep35636 · Cited by 50
Sharma, A. K., Kim, J., Prior, J. T., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2014) · Inorganic Chemistry · doi:10.1021/ic500926c · Cited by 48
Identifying Insulin Fibril Conformational Differences by Thioflavin-T Binding Characteristics
Žiaunys, M., Sakalauskas, A., & Smirnovas, V. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01178 · Cited by 48
LeVine, H. (2005) · Biochemistry · doi:10.1021/bi051252l · Cited by 48
A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques
Elsinghorst, P. W., Härtig, W., Goldhammer, S., Grosche, J., & Gütschow, M. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b909612d · Cited by 47
Skeby, K. K., Sørensen, J., & Schiøtt, B. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405530p · Cited by 47
Kumar, A., Srivastava, S., Tripathi, S., Singh, S. K., Srikrishna, S., & Sharma, A. K. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1074943 · Cited by 46
Discovery of High-Affinity Amyloid Ligands Using a Ligand-Based Virtual Screening Pipeline
Chisholm, T. S., Mackey, M. D., & Hunter, C. A. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c03749 · Cited by 45
McInnes, L. E., Noor, A., Kysenius, K., Cullinane, C. M., Roselt, P. D., McLean, C., Chiu, F. C. K., Powell, A. K., Crouch, P. J., White, J. M., et al. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.8b03466 · Cited by 45
Probing small molecule binding to amyloid fibrils
Buell, A. K., Esbjörner, E. K., Riss, P. J., White, D. A., Aigbirhio, F. I., Tóth, G., Welland, M. E., Dobson, C. M., & Knowles, T. P. J. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c1cp22283j · Cited by 43
Duan, P., Chen, K. J., Wijegunawardena, G., Dregni, A. J., Wang, H. K., Wu, H., & Hong, M. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c12056 · Cited by 43
Benzothiazole‐Based Cycloplatinated Chromophores: Synthetic, Optical, and Biological Studies
Lalinde, E., Lara, R., López, I. P., Moreno, M. T., Alfaro‐Arnedo, E., Pichel, J. G., & Piñeiro‐Hermida, S. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201705267 · Cited by 42
Jensen, J. R., Cisek, K. K., Funk, K. E., Naphade, S. B., Schafer, K. N., & Kuret, J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0003 · Cited by 41
Oligo(ethylene glycol) Derivatives of Thioflavin T as Inhibitors of Protein–Amyloid Interactions
Inbar, P., Li, C. Q., Takayama, S. A., Bautista, M. R., & Yang, J. (2006) · ChemBioChem · doi:10.1002/cbic.200600119 · Cited by 41
The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid-Specific Tracers
Murugan, N. A., Halldin, C., Nordberg, A. K., Långström, B., & Ågren, H. (2016) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6b01586 · Cited by 39
Mao, X., Guo, Y., Wang, C., Zhang, M., Ma, X., Niu, L., Niu, L., Zeng, Q., Wang, C., & Wang, C. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200006h · Cited by 40
Oligovalent Amyloid-Binding Agents Reduce SEVI-Mediated Enhancement of HIV-1 Infection
Capule, C. C., Brown, C. W., Olsen, J. S., Dewhurst, S., & Yang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja210931b · Cited by 38
Amyloid-β probes: Review of structure–activity and brain-kinetics relationships
Eckroat, T. J., Mayhoub, A. S., & Garneau‐Tsodikova, S. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.116 · Cited by 38
Phenolic Bis-styrylbenzenes as β-Amyloid Binding Ligands and Free Radical Scavengers
Flaherty, D. P., Kiyota, T., Dong, Y., Ikezu, T., & Vennerstrom, J. L. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1006929 · Cited by 38
Strategies for molecular imaging dementia and neurodegenerative diseases
Schaller, B. J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2154 · Cited by 38
Negm, N. A. M., Elkholy, Y. M., Ghuiba, F. M., Zahran, M. K., Mahmoud, S. A., & Tawfik, S. M. (2011) · Journal of Dispersion Science and Technology · doi:10.1080/01932691003756902 · Cited by 37
Benzothiazole‐Based Neutral Ratiometric Fluorescence Sensor for Amyloid Fibrils
Mora, A. K., Murudkar, S., Alamelu, A., Singh, P. K., Chattopadhyay, S., & Nath, S. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602981 · Cited by 37
Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future
Dorbala, S., & Kijewski, M. F. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264866 · Cited by 35
Assay To Screen for Molecules That Associate with Alzheimer's Related β-Amyloid Fibrils
Inbar, P., Bautista, M. R., Takayama, S. A., & Yang, J. (2008) · Analytical Chemistry · doi:10.1021/ac702592f · Cited by 35
Yang, T., Wang, X., Zhang, C., Ma, X., Wang, K., Wang, Y., Luo, J. H., Liu, Y., Yao, C., & Wang, X. (2015) · Chemical Communications · doi:10.1039/c5cc08898d · Cited by 35
Tao, R., Wang, N., Shen, T., Tan, Y., Ren, Y., Wei, W., Liao, M., Tan, D., Tang, C., Xu, N., et al. (2022) · Theranostics · doi:10.7150/thno.68743 · Cited by 34
Rana, M., Cho, H., Arya, H., Bhatt, T. K., Bhar, K., Bhatt, S., Mirica, L. M., & Sharma, A. K. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00502 · Cited by 33
Amyloid Imaging in Alzheimer’s Disease and Other Dementias
Fodero‐Tavoletti, M. T., Cappai, R., McLean, C., Pike, K. E., Adlard, P. A., Cowie, T., Connor, A. R., Masters, C. L., Rowe, C. C., & Villemagne, V. L. (2009) · Brain Imaging and Behavior · doi:10.1007/s11682-009-9067-2 · Cited by 33
Metadata
- Authors
- Lockhart, A., Ye, L., Judd, D. B., Merritt, A. T., Lowe, P. N., Morgenstern, J. L., Hong, G., Gee, A. D., & Brown, J.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- Corresponding author
- Lockhart, Andrew
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 280
- Issue
- 9
- Pages
- 7677-7684
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972816877
- Cited by
- 213
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 3 · 2018: 9 · 2017: 11 · 2016: 13 · 2015: 10 · 2014: 10 · 2013: 10 · 2012: 13
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- Alzheimer's disease, thioflavin T, amyloid-beta fibrils, Aβ(1-40), PET imaging agents, benzothiazole ligands, binding sites, ligand binding affinity, halogen substitution, amyloid plaques, radioligand binding, imidazo[1,2-a]pyridine derivatives
- MeSH terms
- Alzheimer Disease, Binding Sites, Binding, Competitive, Centrifugation, Density Gradient, Dose-Response Relationship, Drug, Humans, Kinetics, Ligands, Models, Biological, Models, Chemical, Peptide Fragments, Peptides, Protein Binding, Spectrometry, Fluorescence, Thiazoles, Amyloid beta-Peptides, Fluorescence Resonance Energy Transfer, Positron-Emission Tomography, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
